Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Posten Norge sells Bring Citymail
Mandate

Posten Norge sells Bring Citymail

March 20, 2018 IT, Telecommunications and Outsourcing

Vinge has advised Posten Norge in connection with the sale of Bring Citymail to the German private equity company Allegra Capital.

Bring Citymail is the second largest actor on the Swedish market and has a turnover of approximately SEK two billion and approximately 3 600 employees. 

In 2013, Bring Citymail established a jointly-owned company together with Dagens Nyheter and Svenska Dagbladet for the distribution of mail and newspapers within the Stockholm area. In connection with Allegra Capital’s acquisition of Bring Citymail, Bring Citymail has disposed of its stake in the jointly-owned company, and the distribution of morning newspapers will be performed by a company which is jointly owned by Dagens Nyheter and Svenska Dagbladet and the distribution of mail will be performed by Bring Citymail.

Vinge’s team primarily consisted of Johan Winnerblad, Malin Ohlin, Marcus Glader, Joacim Rydergård, Mathilda Persson, Andrea Ahlgren and Michaela Cronemyr.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025